Yu Okubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu Okubo has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
Keisuke Asakura
5 shared publications- Kaoru Kaseda
Division of Thoracic Surgery, Department of Surgery Keio University School of Medicine Tokyo Japan
4 shared publications Kyohei Masai
4 shared publicationsKaoru Kaseda
3 shared publications- Keisuke Asakura
Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Tokyo, Japan
3 shared publications - Kyohei Masai
Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine , Tokyo
3 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
A Two-Phase Retargeting Strategy with a Low Assistant Port for Robotic Resection of Pulmonary Sequestration
- 21 October 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
Open AccessA Two-Phase Retargeting Strategy with a Low Assistant Port for Robotic Resection of Pulmonary Sequestration
- Open Access
- 24 September 2026
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 17 (4) , e70080
Sequential and Concurrent C5 and Neonatal Fc Receptor Inhibition in Prolonged Myasthenic Crisis due to Advanced Invasive Thymoma‐Associated Myasthenia Gravis: A Case Report and Literature Review
Thymoma‐associated myasthenia gravis (TAMG) is frequently refractory, particularly when complicated by myasthenic crisis in advanced invasive disease. Complement C5 inhibitors and neonatal Fc receptor (FcRn) inhibitors have expanded the treatment of acetylcholine receptor (AChR) antibody‐positive generalized myasthenia gravis; however, their optimal selection, sequencing, and combined use in refractory TAMG remain undefined. We report a case of a 46‐year‐old man with Masaoka–Koga stage IVa invasive thymoma and pleural dissemination who developed a prolonged ventilator‐dependent myasthenic crisis after debulking surgery. Immunoadsorption plasmapheresis, intravenous immunoglobulin, and ravulizumab produced only transient benefit. Serum complement activity became undetectable after ravulizumab was switched to zilucoplan (a peptide C5 inhibitor chosen because it is not affected by FcRn blockade), yet sustained respiratory stability was not achieved. Only after subcutaneous efgartigimod was added to ongoing zilucoplan did the patient attain sustained daytime ventilator independence, with a parallel decline in anti‐AChR antibody titer and total immunoglobulin G. He was discharged and remained clinically stable, with no worsening during a subsequent mild infection. Reviewing this case together with previously reported patients who received concurrent or sequentially overlapping C5 and FcRn inhibition, we discuss the biological rationale for dual‐pathway targeting, pharmacological considerations relevant to agent selection and sequencing, and infectious‐safety implications. This temporal association does not establish efficacy; however, combined C5 and FcRn inhibition may be considered, on an individualized basis, in selected refractory TAMG cases when single‐pathway therapy is insufficient.
- 24 September 2026
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 17 (4) , e70080
Open AccessSequential and Concurrent C5 and Neonatal Fc Receptor Inhibition in Prolonged Myasthenic Crisis due to Advanced Invasive Thymoma‐Associated Myasthenia Gravis: A Case Report and Literature Review
Thymoma‐associated myasthenia gravis (TAMG) is frequently refractory, particularly when complicated by myasthenic crisis in advanced invasive disease. Complement C5 inhibitors and neonatal Fc receptor (FcRn) inhibitors have expanded the treatment of acetylcholine receptor (AChR) antibody‐positive generalized myasthenia gravis; however, their optimal selection, sequencing, and combined use in refractory TAMG remain undefined. We report a case of a 46‐year‐old man with Masaoka–Koga stage IVa invasive thymoma and pleural dissemination who developed a prolonged ventilator‐dependent myasthenic crisis after debulking surgery. Immunoadsorption plasmapheresis, intravenous immunoglobulin, and ravulizumab produced only transient benefit. Serum complement activity became undetectable after ravulizumab was switched to zilucoplan (a peptide C5 inhibitor chosen because it is not affected by FcRn blockade), yet sustained respiratory stability was not achieved. Only after subcutaneous efgartigimod was added to ongoing zilucoplan did the patient attain sustained daytime ventilator independence, with a parallel decline in anti‐AChR antibody titer and total immunoglobulin G. He was discharged and remained clinically stable, with no worsening during a subsequent mild infection. Reviewing this case together with previously reported patients who received concurrent or sequentially overlapping C5 and FcRn inhibition, we discuss the biological rationale for dual‐pathway targeting, pharmacological considerations relevant to agent selection and sequencing, and infectious‐safety implications. This temporal association does not establish efficacy; however, combined C5 and FcRn inhibition may be considered, on an individualized basis, in selected refractory TAMG cases when single‐pathway therapy is insufficient.
- Open Access
- 10 April 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Lobectomy results in a greater increase in the pulmonary artery to aorta ratio compared to sublobar resection: a retrospective study
The pulmonary artery diameter-to-aortic diameter (PA/A) ratio on computed tomography correlates with PA pressure and is a simple tool for estimating the load on the right side of the heart. The purpose of this study was to investigate the change in the PA/A ratio in patients following lung resection according to the specific procedure used. Patients with pathological stage 0-I lung cancer who underwent lobectomy or sublobar resection between 2018 and 2020 were included in this study. The PA/A ratios were measured pre-operatively and at 1 and 3 years post-operatively (POY1 and POY3). Changes over time and factors associated with an increased PA/A ratio were analysed. Of 301 eligible patients, 210 underwent lobectomy and 91 underwent sublobar resection (35 segmentectomies and 56 wedge resections). Age, sex, body mass index, and smoking status were similar between the groups. Cardiac comorbidity and pathological stage 0 disease were more common in the sublobar resection group versus the lobectomy group (20.9% vs. 11.0%, 29.7% vs. 6.2%). Compared with the sublobar resection group, the lobectomy group showed a significantly higher ratio at POY3 (0.823 ± 0.131 vs. 0.786 ± 0.128) and a greater mean increase from baseline to POY1 (difference between groups: 0.039, 95% confidence interval [CI] 0.023-0.05) and from baseline to POY3 (0.065, 95% CI 0.049-0.08). On multivariable analysis, lobectomy independently predicted a postoperative PA/A ratio increase (odds ratio 7.98, 95% CI 3.85-16.6). Compared with sublobar resection, lobectomy is associated with a significantly larger rise in the PA/A ratio, suggesting greater pulmonary-vascular loading after more extensive parenchymal removal. Surveillance of the PA/A ratios may help identify patients at risk of right-heart strain.
- 10 April 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Open AccessLobectomy results in a greater increase in the pulmonary artery to aorta ratio compared to sublobar resection: a retrospective study
The pulmonary artery diameter-to-aortic diameter (PA/A) ratio on computed tomography correlates with PA pressure and is a simple tool for estimating the load on the right side of the heart. The purpose of this study was to investigate the change in the PA/A ratio in patients following lung resection according to the specific procedure used. Patients with pathological stage 0-I lung cancer who underwent lobectomy or sublobar resection between 2018 and 2020 were included in this study. The PA/A ratios were measured pre-operatively and at 1 and 3 years post-operatively (POY1 and POY3). Changes over time and factors associated with an increased PA/A ratio were analysed. Of 301 eligible patients, 210 underwent lobectomy and 91 underwent sublobar resection (35 segmentectomies and 56 wedge resections). Age, sex, body mass index, and smoking status were similar between the groups. Cardiac comorbidity and pathological stage 0 disease were more common in the sublobar resection group versus the lobectomy group (20.9% vs. 11.0%, 29.7% vs. 6.2%). Compared with the sublobar resection group, the lobectomy group showed a significantly higher ratio at POY3 (0.823 ± 0.131 vs. 0.786 ± 0.128) and a greater mean increase from baseline to POY1 (difference between groups: 0.039, 95% confidence interval [CI] 0.023-0.05) and from baseline to POY3 (0.065, 95% CI 0.049-0.08). On multivariable analysis, lobectomy independently predicted a postoperative PA/A ratio increase (odds ratio 7.98, 95% CI 3.85-16.6). Compared with sublobar resection, lobectomy is associated with a significantly larger rise in the PA/A ratio, suggesting greater pulmonary-vascular loading after more extensive parenchymal removal. Surveillance of the PA/A ratios may help identify patients at risk of right-heart strain.
- Open Access
- 27 August 2025
- Published by Elsevier in Lung Cancer
- Vol. 208, 108731
Lineage-specific transcription factor landscape of thymic neuroendocrine tumors
- 27 August 2025
- Published by Elsevier in Lung Cancer
- Vol. 208, 108731
Open AccessLineage-specific transcription factor landscape of thymic neuroendocrine tumors
- Open Access
- 25 August 2025
- Published by Elsevier in Lung Cancer
- Vol. 207, 108727
Prediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal data
- 25 August 2025
- Published by Elsevier in Lung Cancer
- Vol. 207, 108727
Open AccessPrediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal data
- Open Access
- 16 February 2024
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 2 (3) , 488-491
Multiple Lung Resections for Metastases from Pheochromocytoma to Reduce Catecholamine Production
- 16 February 2024
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 2 (3) , 488-491
Open AccessMultiple Lung Resections for Metastases from Pheochromocytoma to Reduce Catecholamine Production
- Open Access
- 3 January 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (1) , rjad714
Nuss procedure for the treatment of pectus excavatum with dyspnea following oropharyngeal cancer surgery: a case report
Pectus excavatum (PE) causes cardiopulmonary dysfunction depending on the degree and form of the depression. The patient was a 74-year-old woman with a history of PE. Fourteen years ago, a total glossolaryngectomy was performed for oropharyngeal cancer. Two years later, the patient gradually experienced difficulty in breathing. Computed tomography (CT) revealed severe PE and right main bronchial stenosis. We performed a Nuss procedure for PE repair to surgically release the stenosis of the right main bronchus. Postoperative chest CT showed improvement in the sternal depression and right main bronchial stenosis. Furthermore, shortness of breath was relieved postoperatively. Oropharyngeal cancer surgery may cause tracheal support disruption, leading to leftward shift and severe stenosis of the right main bronchus due to sternum depression. This is an important report regarding respiratory distress caused by a combination of PE and post-oropharyngeal cancer surgery.
- 3 January 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (1) , rjad714
Open AccessNuss procedure for the treatment of pectus excavatum with dyspnea following oropharyngeal cancer surgery: a case report
Pectus excavatum (PE) causes cardiopulmonary dysfunction depending on the degree and form of the depression. The patient was a 74-year-old woman with a history of PE. Fourteen years ago, a total glossolaryngectomy was performed for oropharyngeal cancer. Two years later, the patient gradually experienced difficulty in breathing. Computed tomography (CT) revealed severe PE and right main bronchial stenosis. We performed a Nuss procedure for PE repair to surgically release the stenosis of the right main bronchus. Postoperative chest CT showed improvement in the sternal depression and right main bronchial stenosis. Furthermore, shortness of breath was relieved postoperatively. Oropharyngeal cancer surgery may cause tracheal support disruption, leading to leftward shift and severe stenosis of the right main bronchus due to sternum depression. This is an important report regarding respiratory distress caused by a combination of PE and post-oropharyngeal cancer surgery.
- Open Access
- 3 November 2023
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2023 (11) , rjad618
Combined Ravitch and Nuss procedure for pectus excavatum with dyspnea following scoliosis repair
Pectus excavatum (PE) is often associated with scoliosis and can elicit cardiovascular disturbances under rare conditions. Here we report a patient who was treated with a combined Ravitch and Nuss procedure for PE with dyspnea following scoliosis repair to improve her symptoms. The patient was a 49-year-old woman with a history of PE and scoliosis. Right inferior pulmonary vein stenosis was caused by posterior spinal fusion for scoliosis prior to the PE repair. We could safely correct the chest wall deformity and treat dyspnea by performing a modified Ravitch repair in combination with the Nuss procedure.
- 3 November 2023
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2023 (11) , rjad618
Open AccessCombined Ravitch and Nuss procedure for pectus excavatum with dyspnea following scoliosis repair
Pectus excavatum (PE) is often associated with scoliosis and can elicit cardiovascular disturbances under rare conditions. Here we report a patient who was treated with a combined Ravitch and Nuss procedure for PE with dyspnea following scoliosis repair to improve her symptoms. The patient was a 49-year-old woman with a history of PE and scoliosis. Right inferior pulmonary vein stenosis was caused by posterior spinal fusion for scoliosis prior to the PE repair. We could safely correct the chest wall deformity and treat dyspnea by performing a modified Ravitch repair in combination with the Nuss procedure.
- 31 October 2023
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 18 (11) , S572
EP08.02-10 Clinicopathological Analyses for Predicting Survival After Salvage Surgery for Initially Unresectable Lung Cancer
- 31 October 2023
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 18 (11) , S572
EP08.02-10 Clinicopathological Analyses for Predicting Survival After Salvage Surgery for Initially Unresectable Lung Cancer
- 19 December 2021
- Published by Elsevier in Journal of Surgical Research
- Vol. 272, 61-68
Assessment of Resectability of Mediastinal Germ Cell Tumor Using Preoperative Computed Tomography
- 19 December 2021
- Published by Elsevier in Journal of Surgical Research
- Vol. 272, 61-68
Assessment of Resectability of Mediastinal Germ Cell Tumor Using Preoperative Computed Tomography